Back to User profile » Dr Yanyang Liu
Papers published by Dr Yanyang Liu:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anticancer Effects of ACT001 via NF-κB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1
Liu Y, Wang L, Liu J, Xie X, Hu H, Luo F
Cancer Management and Research 2020, 12:5131-5139
Published Date: 26 June 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway
Hu H, Liu Y, Tan S, Xie XX, He J, Luo F, Wang L
Cancer Management and Research 2020, 12:3579-3587
Published Date: 19 May 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
Wang Y, Tu L, Du C, Xie X, Liu Y, Wang J, Li Z, Jiang M, Cao D, Yan X, Luo F
OncoTargets and Therapy 2018, 11:5559-5567
Published Date: 6 September 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer
Liu YY, Tu L, Wang L, Long J, Wang J, Wang Y, Luo F, Cao D
OncoTargets and Therapy 2016, 9:6581-6595
Published Date: 25 October 2016